As the second most common cancer among men, prostate cancer is a major health concern. In fact, research by the American Cancer Society shows that almost 1 in 9 men will be diagnosed with prostate cancer at some point in their lives.
For advanced prostate cancer patients, treatment options may be limited. However, Xofigo treatment is a game changer for those suffering from this condition.
Xofigo treatment (radium Ra 223 dichloride) is a targeted alpha-emitter radiopharmaceutical that is used to treat advanced prostate cancer. Xofigo works by selectively targeting and delivering radiation to bone metastases of prostate cancer, which can prolong a patient’s survival and also help with symptom relief.
So, what are the benefits of Xofigo treatment for advanced prostate cancer patients?
Benefit 1: Improved Overall Survival
Clinical studies show that Xofigo treatment can improve overall survival in advanced prostate cancer patients. In a randomized clinical trial, men who received Xofigo treatment lived an average of 14.9 months, compared to 11.3 months for those who received a placebo.
Benefit 2: Reduced Pain and Improved Quality of Life
In addition to increasing overall survival, Xofigo treatment can also help reduce pain associated with bone metastases. Clinical studies show that patients receiving Xofigo treatment report less bone pain and a better quality of life compared to those receiving a placebo.
Benefit 3: Fewer Side Effects Compared to Other Treatments
Compared to other treatments for advanced prostate cancer, such as chemotherapy, Xofigo treatment has fewer side effects. Patients receiving Xofigo treatment experience less fatigue, nausea, and vomiting compared to those receiving other treatments.
Case Study: John’s Experience with Xofigo Treatment
John, a 64-year-old man with advanced prostate cancer, was experiencing severe pain in his back and ribs due to bone metastases. His doctor recommended Xofigo treatment, and John received six injections over the course of four months.
After his second injection, John noticed a significant improvement in his pain levels. He was able to move around more comfortably and even started walking daily. John received his final injection in January 2021 and has continued to experience pain relief and a better quality of life.
Conclusion
Xofigo treatment is a promising treatment option for advanced prostate cancer patients. It can improve overall survival, reduce pain, and improve quality of life, all while having fewer side effects compared to other treatments. If you or a loved one is suffering from advanced prostate cancer, talk to your doctor about Xofigo treatment and how it may benefit you.
(Note: Do you have knowledge or insights to share? Unlock new opportunities and expand your reach by joining our authors team. Click Registration to join us and share your expertise with our readers.)